Attwood et al., "A Light Scattering Study on Oil-In-Water Microemulsions", International Journal of Pharmaceutics, 52, 165-171 (1989). |
Bagdade et al., "Effects of Tamoxifen Treatment on Plasma Lipids and Lipoprotein Lipid Composition", J. Clinical Endocrinology and Metabolism, 70, 1132-1135 (1990). |
Barath et al., "Low Dose of Antitumor Agents Prevents Smooth Muscle Cell Proliferation After Endothelial Injury", JACC, 13, 252A, Abstract No. 252A (Feb. 1989). |
Bertelli et al., "Adjuvant Tamoxifen in Primary Breast Cancer: Influence on Plasma Lipids and Antithrombin III Levels", Breast Cancer Res. and Treatment, 12, 307-310 (1988). |
Bruengger et al., "Smooth Muscle Cell of the Canine Prostate in Spontaneous Benign Hyperplasia, Steroid Induced Hyperplasia and Estrogen or Tamoxifen Treated Dogs", J. Urology, 130, 1208-1210 (Dec. 1983). |
Bruning et al., "Tamoxifen, Serum Lipoproteins and Cardiovascular Risk", Br. J. Cancer, 58, 497-499 (1988). |
Butta et al., "Induction of Transforming Growth Factors .beta..sub.1 in Human Breast Cancer in Vivo Following Tamoxifen Treatment ", Cancer Res., 52, 4261-4264 (Aug. 1, 1992). |
Craig et al., "Modern Pharmacology", Little Brown and Company, p. 399 (1982). |
Dimond et al., "TGF-.beta. Shows Potential as Therapeutic Agent for Macular Holes", Genetic Eng. News, 7, 19 (Feb. 1, 1993). |
Fanelli et al., "Restenosis Following Coronary Angioplasty", Amer. Heart J., 119, 357-368 (Feb. 1990). |
Farhat et al., "In Vitro Effect of Oestradiol on Thymidine Uptake in Pulmonary Vascular Smooth Muscle Cell: Role of the Endothelium", Br. J. Pharamcol., 107, 679-683 (1992). |
Fischer et al., "A Possible Mechanism in Arterial Wall for Mediation of Sex Difference in Atherosclerosis," Experimental and Molecular Pathology, 43, 288-296 (1985). |
Forrester et al., "A Paradigm for Restenosis Based on Cell Biology: Clues for the Development of New Preventive Therapies", JACC, 17, 758-769 (Mar. 1, 1991). |
Gasco et al., "In Vitro Permeation of Azelaic Acid From Viscoized Microemulsions", Int'l J. of Pharmaceutics, 69, pp. 193-196 (1991). |
Grainger et al., "Hexamethylenebisacetamide Selectively Inhibits the Proliferation of Human and Rat Vascular Smooth-Muscle Cells", Biochem J., 283, 403-408 (1992). |
Grainger et al., "Tamoxifen Decreases the Rate of Proliferation of Rat Vascular Smooth Cells in Culture by Inducing the Production of Transforming Growth Factor b", Biochem. J., 294, 109-112 (1993). |
Grainger et al., "Proliferation of Human Smooth Muscle Cells Promoted by Lipoprotein (a)", Science, 260, 1655-1658 (1993). |
Hanke et al., "Inhibition of Cellular Proliferation After Experimental Balloon Angioplasty by Low-Molecular-Weight Heparin", Circulation, 85, 1548-1556 (Apr. 1992). |
Henriksson et al., "Hormonal Regulation of Serum Lp (a) Levels", J. Clin. Invest., 89, 1166-1171 (Apr. 1992). |
Hofmann et al., "Enhancement of the Antiproliferative Effect of cis Diamminedichloroplatinum(II) and Nitrogen Mustard by Inhibitors of Protein Kinase C", Int. J. Cancer, 42, 382-388 (1988). |
Hwang et al., "Effects of Platelet-Contained Growth Factors (PDGF, EGF, IGF-1, and TGF-.beta.) on DNA Synthesis in Porcine Aortic Smooth Muscle Cells in Culture", Exp. Cell Res., 200, 358-360 (1992). |
Jordan, "Long-Term Tamoxifen Therapy to Control or to Prevent Breast Cancer: Laboratory Concept to Clinical Trials", Hormones Cell Biology and Cancer: Perspectives and Potentials; Alan R. Liss, Inc.; pp. 105-123 (1988). |
Kirschenlohr et al., "Adult human aortic smooth muscle cells in culture produce active TGF-.beta.", Am. J. Physiol., 261, C571-C576 (Aug. 1993). |
Knabbe, C. et al., "Induction of Transforming Growth Factor .beta. by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF-7 Cells", Am. J. Clin. Oncol., 14, pp. S15-S20 (1991). |
Koff et al., "Negative Regulation of G1 in Mammalian Cells: Inhibition of Cyclin E-Dependent Kinase by TGF-.beta.", Science, 260, 536-538 (Apr. 23, 1993). |
Lefer et al., "Mechanisms of the Cardioprotective Effect of Transforming Growth Factor .beta..sub.1 Feline Myocardial Ischemia and Reperfusion", PNAS (USA), 90, 1018-1022 (Feb. 1993). |
Lefer, "Role of Transforming Growth Factor .beta. is cardioprotection of the ischemic-reperfused myocardium", Growth Factors and the Cardiovascular System, P. Cummins, ed., Kluwer Acedemic Publishers, pp. 249-260 (1993). |
Levy et al., "Drug Release From Submicronized O/W Emulsion: A New In Vitro Kinetic Evaluation Model", International Journal of Pharmaceutics, 66, 29-37 (1990). |
Li et al., "Structure and Dynamics of Microemulsions Which Mimic the Lipid Phase of Low-Density Lipoproteins", Biochimica et Biophysica Acta, 1042, 42-50 (1990). |
Liu et al, "Restenosis After Coronary Angioplasty-Potential Biologic Determinants and Role of Internal Hyperplasia", Circulation, 79, 1374-1387 (Jun. 1989). |
Love et al., "Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women", Annals of Internal Medicine, 115, 860-864 (Dec. 1, 1991). |
Love et al., "Effects of Tamoxifen Therapy on Lipid and Lipoprotein Levels in Postmenopausal Patients with Node-Negative Breast Cancer", J. Natl. Cancer Inst., 82, 1327-1332 (Aug. 15, 1990). |
McCaffrey et al., "Transforming Growth Factor-.beta. Activity is Potentiated by Heparin via Dissociation of the Transforming Growth Factor-.beta./.alpha..sub.2 -Macroglobulin Inactive Complex", J. Cell Biol., 109, 441-448 (Jul. 1989). |
McCague et al., "Synthesis of 4-Stannylated Tamoxifen Analogues; Useful Precursors to Radiolabelled Idoxifene and Aziridinyl 4-Iodotamoxifen", J. Labelled Cmpds. Radiopharmaceuticals, 34, 297-302 (1993). |
McCaroll et al., "Preliminary Studies on the Regulation of Secretion of Latent Transforming Growth Factor-.beta. (TGF-.beta.) by Endothelial Cells in Culture", Clin. Chem., 36, p. 1152, Abstract No. 0934 (1990). |
McDonald et al., "Fatal Myocardial Infarction in the Scottish Adjuvant Tamoxifen Trial", B. Med. J., 303, 435-437 (Aug. 24, 1991). |
Merrilees et al., "Synthesis of TGF-.beta..sub.1 by Vascular Endothelial Cells is Correlated with Cell Spreading", J. Vasc. Res., 29, 376-384 (1992). |
Morisaki et al., "Effects of Transforming Growth Factor-.beta..sub.1 on Growth of Aortic Smooth Muscle Cells: Influences of Interaction with Growth Factors, Cell State, Cell Phenotype, and Cell Cycle", Atherosclerosis, 88, 227-234 (1991). |
Nikol et al., "Expression of Transforming Growth Factor-.beta..sub.1 is Increased in Human Vascular Restenosis Lesions", J. Clin. Invest., 1582-1592 (Oct. 1992). |
Nolvadex Tamoxifene Citrate, ICI Pharma, 64033-02, Rev. L/07/92. |
Pathak et al., "Enhanced Stability of Physostigmine Salicylate in Submicron O/W Emulsion", International Journal of Pharmaceutics, 65, 169-175 (1990). |
Popma et al., "Factors Influencing Restenosis after Coronary Angioplasty", Am. J. of Med., 88, 1-16N-1-24N (Jan. 1990). |
Pouton, C. W., "Self-Emulsifying Drug Delivery Systems: Assessment of the Efficiency of Emulsification", International Journal of Pharmaceutics, 27, 335-348 (1985). |
Rauterberg et al., "Collagens in Atherosclerotic Vessel Wall Lesions", Current Topics in Pathology, 87, 163-191 (1993). |
Ross et al., "Chronic Inflammation, PDGF, TGFB, and Smooth Muscle Proliferation", Molecular Mechanisms of Vascular Diseases, p. 96 Abstract G 006. (1990). |
Ross, "The Pathogenesis of Atherosclerosis: A Perspective for the 1990s", Nature, 362, 801-809 (Apr. 29, 1993). |
Schoenemanne et al., "The Differential Diagnosis of Spontaneous Pneumonthorax and Pulmonary Lymphangioleiomyomatosis Clinical Picture Diagnosis and Therapy", Chirug, 61, 301-303 (1990)--English Language Abstract Only. English abstract reported at 90, 432367 Biosis (1990). |
Schwartz et al., "Restenosis After Balloon Angioplasty--A Practical Proliferative Model in Porcine Coronary Arteries", Circulation, 82, 2190-2200 (Dec. 1990). |
Schwartz et al., "The Restenosis Paradigm Revisited: An Alternative Proposal for Cellular Mechanisms", JACC, 20, 1284-1293 (Nov. 1, 1992). |
Shewmon et al., "Tamoxifen Lowers Lp(a) in Males with Heart Disease", Supplement I Circulation, 86, I-338, Abstract No. 1345, (Oct. 1992). |
Snow et al., "Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells", Am. J. Path., 137, 313-330 (1990). |
Steele et al., "Balloon Angioplasty-Natural History of the pathophysiological Response to Injury in a Pig Model", Cir. Res., 57, 105-112 (Jul. 1985). |
Streuli et al., "Extracellular Matrix Regulates Expression of the TGF-.beta..sub.1 Gene", J. of Cell Biol., 120, 253-260 (Jan. 1993). |
T. R. Tice et al., "Biodegradable controlled-release parenteral systems", Pharmaceutical Technology, pp. 26-35, (Nov. 1984). |
Vargas et al., "Oestradiol inhibits smooth muscle cell proliferation of Pig Coronary Artery", Br. J. Pharmacol. 109, 612-617 (1993). |
Weissberg et al., "Approaches to the Development of Selective inhibitors of Vascular Smooth Muscle Cell Proliferation", Cardiovascular Res., 27, 1191-1198 (1993). |
Weissberg et al., "Effects of TGF-.beta. on Vascular Smooth Muscle Cell Growth", In: Growth Factors and the Cardiovascular System, P. Cummins, ed., Kluwer Academic Publishers, pp. 189-205 (1993). |
Wolinsky et al., "Use of a Perforated Balloon Catheter to Deliver Concentrated Heparin Into the Wall of the Normal Canine Artery", JACC, 15, 475-481 (Feb. 1990). |
Zuckerman et al., "Cytokine Regulation of Macrophage apo E Secretion: Opposing Effects of GM-CSF and TGF-.beta.", Atherosclerosis, 96, 203-214 (1992). |
R. K. Assoian, et al., "Type .beta. Transforming Growth Factor in Human Platelets: Release During Platelet Degranulation and Action of Vascular Smooth Muscle Cells", J. Cell Biol, 102, 1217-1223 (Apr., 1986). |
S. K. Chander, et al., "Pyrrolidino-4-idotamoxifen and 4-idotamamoxifen New Analogues of the Antiestrogen Tamoxifen for the Treatment of Breast Cancer", Cancer Res., 51, 5851-5858 (Nov., 1991). |
D. J. Grainger, et al., "Effect of Tamoxifen in the Rat Carotid Injury Model In Vivo", Manuscript in Preparation, (1986). |
P. C. Harpel, et al., "Plasmin Catalysis Binding of Lipoprotein (A) to Immobilized Fibrinogen and Fibrin.", Proc. Natl. Acad. Sci. USA, 86, 3847-3851 (1989). |
N. Koyama, et al., "Regulation of Smooth Muscle Cells Migration by a New Autocrine Migration Factor and TGF-beta", Abstracts from the 64th Scientific Sessions, II-459 (1989). |
J. Massague, "The Transforming Growth Factor-B Family.", Ann Rev. Cell Biol., 6, 597-641 (1990). |
Z. Reiner, et al., "Antiestogen Tamoxifen Reduces Lipoprotein(a)". (1990). |
S. Sedlacek, "Estrogenic Properties of Tamoxifen on Serum Lipids in Postmenopausal Women with Breast Cancer (BCA)", Breast Cancer Research and Treatment, 14, Abstract No. 82, p. 153 (1989). |
L. M. Wakefield, et al., "Latent Transforming Growth Factor-.beta. from Human Platelets: A High Molecular Weight Complex Containing Precursor Sequences.", J. Biol. Chem., 263, 7646-7654 (Jun., 1988). |
R. L. Wilensky, et al., "Direct Intraarterial Wall Injection of Microparticles via a Catheter: A Potential Drug Delivery Strategy Following Angioplasty", American Heart Journal, 122, 1136-1140 (Oct., 1991). |
Prevention of Coronary Heart Disease", Avery's Drug Treatment--Principles and Practice of Clinical Pharmacology and Therapeutics, Third Edition, Speight, T. M. (ed.), ADIS Press Limited, Auckland, New Zealand, pp. 594-595 (1987). |
N. Koyama, et al., "Regulation of Smooth Muscle Cells Migration be a New Autocrine Migration Factor and TGF-.beta., Circulation, 84, II-459, Abstract 1829 (1991). |
Z. Reiner, et al., "Antiestrogen Tamoxifen Reduces Lipoprotein (a)," Abstracts, The Second International Conference on Lipoprotein (a), New Orleans, LA, p. 124 (Nov. 12-14, 1992). |